[1]
M. Kim, C. Barnes, and W. Charlton, “ASSOCIATION BETWEEN GLUCOCORTICOID DOSE WITH BMI AND GLUCOCORTICOID-RELATED COMORBIDITIES: DATA FROM TILDACERFONT PHASE 2A TRIALS IN CLASSIC CONGENITAL ADRENAL HYPERPLASIA”, J ASEAN Fed Endocr Soc, vol. 37, no. 2, p. 13, Oct. 2022.